Loading…
136 Neuropsychiatric lupus with hepatitis in a child with cmv co-infection: is cmv a simple by-stander?
Background and AimsCytomegalovirus (CMV) infection at first presentation in paediatric SLE (pSLE) is a rare phenomenon.Aim- To report an adolescent girl with SLE presenting with neurological and hepatic manifestations and CMV co- infection.MethodsA 12 year old girl presented with history of fever, m...
Saved in:
Published in: | Lupus science & medicine 2017-03, Vol.4 (Suppl 1), p.A62 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and AimsCytomegalovirus (CMV) infection at first presentation in paediatric SLE (pSLE) is a rare phenomenon.Aim- To report an adolescent girl with SLE presenting with neurological and hepatic manifestations and CMV co- infection.MethodsA 12 year old girl presented with history of fever, maculopapular rash over the trunk, malar rash and jaundice. She had altered behaviour with agitation, disorientation, fluctuating consciousness, hallucinations, and altered sleep. On examination, she had malar rash, icterus, and hepatosplenomegaly. She also had catatonia, mutism, would stare intermittently, had low speech output and psychomotor retardation with rigidity. There was no focal deficit. Investigations revealed pancytopenia, transaminitis, conjugated hyperbilirubinemia, normal renal functions, antinuclear antibody (ANA) - positive (homogenous pattern), high anti-dsDNA with hypocomplementemia.Liver biopsy revealed steatosis with hepatitis. Screen for infections was negative, except CMV. Very high levels of CMV DNA in blood were noted on PCR. It was a clinical dilemma as to whether CMV was causative, co-infection or a re-activation due to immunosuppression. Magnetic resonance imaging (MRI) brain showed cortical atrophy. There was no evidence of any vascular involvement.She was treated with intravenous (IV) methylprednisolone, IV cyclophosphamide pulses and oral valganciclovir.Abstract 136 Table 1Laboratory investigationsResultsA repeat CMV viral load done after six weeks of oral valganciclovir therapy was undetectable. She has been followed up for a period of 6 months. She has shown marked improvement in her neurological status and transaminases have normalised.ConclusionsCMV is an important pathogen in patients with SLE; however its exact pathogenesis needs more research. |
---|---|
ISSN: | 2053-8790 |
DOI: | 10.1136/lupus-2017-000215.136 |